We also demonstrated that the expression of G0S2 was higher in post-operative recurrence diagnosed as WHO grade IV secondary GBM compared with initial glioma diagnosed as WHO grade II diffuse astrocytoma in the same patient. Here, G0S2 is linked to glioma.